Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Syntaxin 4 ELISA Kit (AC2676)
Cat.#: ASET-1265
Specifications
Description Human Syntaxin 4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Syntaxin 4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.017 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.5-8 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1399 Mouse alpha 2a Adrenergic Receptor ELISA Kit (AC2810) Quantitative inquiry ASET-1029 Human APLP2 ELISA Kit (AC2440) Quantitative inquiry ASET-2130 Rat Adenosine Receptor A2a ELISA Kit (AC3541) Quantitative inquiry ASET-2442 Human Ephrin B2 ELISA Kit (AC3853) Quantitative inquiry ASET-1468 Sheep IL-6 ELISA Kit (AC2879) Quantitative inquiry ASET-1449 Mouse TrkB ELISA Kit (AC2860) Quantitative inquiry ASET-1053 Human Pea3 ELISA Kit (AC2464) Quantitative inquiry ASET-1307 Rat TNF Receptor II ELISA Kit (AC2718) Quantitative inquiry ASET-2408 Human AKAP12 ELISA Kit (AC3819) Quantitative inquiry ASET-1271 Human Nestin ELISA Kit (AC2682) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket